References
- Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH, Palmer S, Browne C, Wallace C. Sudden death in psychiatric patients. Br J Psychiatry 1998;172: 331–336.
- Frasure-Smith and Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005;67(suppl 1): S19–25.
- Barth J, Schumacher M, Hermann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta analysis. Psychosom Med 2004;66(6): 802–813.
- Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, Mark DB, Sheps DS, Taylor B, Froelicher ES. Depression and coronary heart disease: recommendations for screening, referral, and treatment. A science advisory for the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research; endorsed by the American Psychiatric Association. Circulation 2008;118: 1768–1775.
- Glassman AH, O' Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McIvor M. Setraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Setraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288: 701–709.
- Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, Kaufmann PG, Mitchell P, Norman J, Powell LH, Racyznski JM, Schneiderman N. Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289(23): 3106–3116.
- Honig A, Kuyper A, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J. MIND-IT Investigators. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 2007;69(7): 606–613.
- de Jonge P, van den Brink RH, Spijkerman TA, Ormel J. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol 2006;48(11): 2204–2208.
- Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Coronary heart disease/myocardial infarction: prospective study of phobic anxiety and the risk of coronary heart disease in men. Circulation 1994;89: 992–1997.
- Davidson KW, Burg MM, Kronish IM, Shimbo D, Dettenborn L, Mehran R, Vorchheimer D, Clemow L, Shwartz JE, Lesperance F, Rieckmann N. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psy 2010;67(5): 480–488.
- Hasler G, Drevets WC, Manji HK, Charney DS. Discovery endophenotypes for major depression. Neuropsychopharmacology 2004;29(10): 1765–1781.
- Hoen PW, Whooley MA, Martens EJ, Na B, van Melle JP, de Jonge P. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. JACC 2010;56(11): 838–844.
- Gorwood P. Neurobiological mechanisms of anhedonia. 2008;10(3): 291–299.
- Zafar MU, Paz-Yepes M, Shimbo D, Vilahur G, Burg MM, Chaplin W, Fuster V, Davidson KW, Badimon JJ. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 2010;31: 1573–1582.
- Wittstein IL. Depression, anxiety and platelet reactivity in patients with coronary heart disease. Eur Heart J 2010;31: 1548–1550.
- Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005;67(suppl 1): S29–S33.
- Cooper DC, Milic MS, Tafur JR, Mills PJ, Bardwell WA, Ziegler MG, Dimsdale JE. Adverse impact of mood on flow-mediated dilation. Psychosom Med 2010;72: 122–127.